First human tests: new drug SR750 studied in china
NCT ID NCT06932536
Summary
This early-stage study tested how a new drug called SR750 moves through the body and how safe it is in healthy people. Researchers gave the drug to 40 healthy Chinese volunteers and compared them to others who received a placebo. The main goal was to understand the drug's safety profile and how the body processes it before testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU)
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.